GLTO
Galecto, Inc.
Latest Form 4:Sale$5KbyWinslow Garrett (General Counsel) · filed Jan 6, 2026
Galecto, Inc. (GLTO) has 7 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Feb 12, 2026.
- Industry:Medical - Pharmaceuticals
- CEO:Jennifer A. Jarrett
- Employees:7
- HQ:Boston, MA, US
- IPO:2020-10-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$23K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Winslow GarrettFirst filing | General Counsel | Sale | 255 | $5K | Jan 6 | SEC ↗ |
Firmani LoriFirst filing | Chief Financial Officer | Sale | 135 | $3K | Jan 6 | SEC ↗ |
Schambye Hans T.First filing | Chief Executive Officer | Sale | 700 | $15K | Jan 6 | SEC ↗ |